Overactive Bladder WisdomCard™

Targacept plans to pursue development of TC-5214 for overactive bladder

news-medical.net — “Targacept, Inc., a clinical-stage biopharmaceutical company developing novel NNR Therapeutics, today announced that it plans to pursue development of TC-5214 as a treatment for overactive bladder (OAB).” View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on September 6, 2012 at 8:08 am By:

Bladder_OAB Overactive Bladder OW Health

Targacept plans to pursue development of TC-5214 for overactive bladder: Targacept, Inc., a clinical-stage bioph... http://t.co/3tl10Ztz

9 months ago...

Reply

Retweet

Favorite

Targacept to develop TC-5214 for overactive bladder - Yahoo! Finance

finance.yahoo.com — “From Yahoo! Finance: Targacept plans to pursue development of TC-5214 as a treatment for overactive bladder. Based on TC-5214’s unique pharmacokinetic profile, an analysis of data from a completed clinical program and findings ...” View full resource at finance.yahoo.com

  • View Related
  • Share

Most Recently Shared on September 5, 2012 at 2:05 pm By:

Bladder_OAB Overactive Bladder OW Health

Targacept to develop TC-5214 for overactive bladder: Targacept plans to pursue development of TC-5214 as a treat... http://t.co/E3StEz1f

9 months ago...

Reply

Retweet

Favorite